Correlation Between Recursion Pharmaceuticals and Affimed NV

Can any of the company-specific risk be diversified away by investing in both Recursion Pharmaceuticals and Affimed NV at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Recursion Pharmaceuticals and Affimed NV into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Recursion Pharmaceuticals and Affimed NV, you can compare the effects of market volatilities on Recursion Pharmaceuticals and Affimed NV and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Recursion Pharmaceuticals with a short position of Affimed NV. Check out your portfolio center. Please also check ongoing floating volatility patterns of Recursion Pharmaceuticals and Affimed NV.

Diversification Opportunities for Recursion Pharmaceuticals and Affimed NV

-0.02

Correlation Coefficient

Recursion Pharmaceuticals  Affimed NV

Good diversification

The 3 months correlation between Recursion and Affimed is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Recursion Pharmaceuticals and Affimed NV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Affimed NV and Recursion Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Recursion Pharmaceuticals are associated (or correlated) with Affimed NV. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Affimed NV has no effect on the direction of Recursion Pharmaceuticals i.e., Recursion Pharmaceuticals and Affimed NV go up and down completely randomly.

Pair Corralation between Recursion Pharmaceuticals and Affimed NV

Given the investment horizon of 90 days Recursion Pharmaceuticals is expected to generate 1.24 times more return on investment than Affimed NV. However, Recursion Pharmaceuticals is 1.24 times more volatile than Affimed NV. It trades about 0.06 of its potential returns per unit of risk. Affimed NV is currently generating about -0.18 per unit of risk. If you would invest  657.00  in Recursion Pharmaceuticals on September 13, 2024 and sell it today you would earn a total of  89.00  from holding Recursion Pharmaceuticals or generate 13.55% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Recursion Pharmaceuticals  vs.  Affimed NV

Recursion Pharmaceuticals

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Recursion Pharmaceuticals are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent basic indicators, Recursion Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.

Affimed NV

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Affimed NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's primary indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with Recursion Pharmaceuticals and Affimed NV

The main advantage of trading using opposite Recursion Pharmaceuticals and Affimed NV positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Recursion Pharmaceuticals position performs unexpectedly, Affimed NV can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Affimed NV will offset losses from the drop in Affimed NV's long position.

The idea behind Recursion Pharmaceuticals and Affimed NV pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.